newsfilter
← Latest News
Business Wire·

Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2022

Regulatory News: Aptorum Group Limited (NASDAQ:APM, PARIS:APM) ("Aptorum Group" or the "Company"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious diseases, today provided a b